| ARG1 | Arginase 1 |
| BSA | Bovine serum albumin |
| CAF | Cancer-associated fibroblast |
| CCL2 | C-C motif chemokine ligand 2 |
| CCR2 | C-C chemokine receptor 2 |
| CRC | Colorectal cancer |
| CSF1 | Colony-stimulating factor 1 |
| CSF1R | Colony-stimulating factor 1 receptor |
| Cur | Curcumin |
| DC | Dendritic cell |
| DOX | Doxorubicin |
| GBM | Glioblastoma |
| GSDME | Gasdermin E |
| HCC | Hepatocellular carcinoma |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| ICD | Immunogenic cell death |
| IFN-γ | Interferon gamma |
| iNOS | Inducible nitric oxide synthase |
| LC-MS | Liquid chromatography–mass spectrometry |
| LUAD | Lung adenocarcinoma |
| MAPK | Mitogen-activated protein kinase |
| MDSC | Myeloid-derived suppressor cell |
| miR | MicroRNA |
| NF-κB | Nuclear factor kappa B |
| NK | Natural killer |
| NP | Nanoparticle |
| PD | Pharmacodynamics |
| PDA | Polydopamine |
| PK/PD | Pharmacokinetics/pharmacodynamics |
| PLGA | Poly(lactic-co-glycolic acid) |
| ROS | Reactive oxygen species |
| siRNA | Small interfering RNA |
| STAT | Signal transducer and activator of transcription |
| TAM | Tumor-associated macrophage |
| TCR | T-cell receptor |
| TGF-β | Transforming growth factor beta |
| TIDE | Tumor Immune Dysfunction and Exclusion |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| TNF-α | Tumor necrosis factor alpha |
| VEGF | Vascular endothelial growth factor |